Cover Image
市場調查報告書

智慧藥丸的全球市場預測 2024年:膠囊內視鏡、藥物遞輸、病患監測

Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 253270
出版日期 內容資訊 英文 127 Pages
訂單完成後即時交付
價格
Back to Top
智慧藥丸的全球市場預測 2024年:膠囊內視鏡、藥物遞輸、病患監測 Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024
出版日期: 2015年03月25日 內容資訊: 英文 127 Pages
簡介

由於生活方式和飲食習慣的變化,高齡化等,腸胃障礙日益廣為滲入我們每天的生活。可是,幾個腸胃障礙,達到小腸的有效醫療設備不足,治療方法與出血的原因仍未解明。雖然有幾個彈性高的內視鏡,但是患者對於管插入體內感到不舒服。其中,由於醫療科學及技術的演進和微技術、奈米技術的出現,開發了小型的無線膠囊。這些設備也可用於精確的藥物輸送和有效的患者監測。透過生物MEMS實現的這個新的方法稱作智慧藥丸,不僅帶給患者舒適性,醫療提供者可實行即時有效的治療。

本報告提供智慧藥丸技術市場現況與展望調查分析、智慧藥丸的技術與用途、各用途的發展過程、技術趨勢、引進區域、成長推進因素/阻礙要素等分析、智慧藥丸技術為基礎的設備市場變化與預測、技術開發發展藍圖、投資、資金籌措環境分析、各地區的趨勢、分析師的建議、主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 智慧藥丸:技術概要

  • 智慧藥丸技術:概要
  • 膠囊內視鏡 (相機藥丸技術)
    • 到目前為止的過程:概要
    • 技術趨勢
    • 引進領域
  • 監測腸胃的智慧藥丸技術
    • 到目前為止的過程:概要
    • 技術趨勢
    • 引進領域
  • 由於智慧藥丸的藥物輸送系統
    • 到目前為止的過程:概要
    • 技術趨勢
    • 引進領域

第4章 技術趨勢分析

  • 智慧藥丸技術的用途:藍圖
  • 技術價值鏈分析
    • 智慧藥丸:價值鏈
    • 價值鏈的差距的清單
    • 強化智慧藥丸市場價值鏈的策略候補
  • 技術趨勢、智慧藥丸的引進可能性

第5章 智慧藥丸的市場環境分析

  • 市場規模:潛在可尋址市場
  • 全球市場預測
  • 相機藥丸技術
    • 主要的技術方面、產業方面的成長推進因素
    • 阻礙成長要素、課題
  • 智慧藥丸技術為基礎的GI監控系統:市場動態
    • 主要的技術方面、產業方面的成長推進因素
    • 阻礙成長要素、課題
  • 智慧藥丸為基礎的藥物輸送系統:市場動態
    • 主要的技術方面、產業方面的成長推進因素
    • 阻礙成長要素、課題
  • 新的技術趨勢
  • 智慧藥丸:大環境分析

第6章 投資者分析、投資機會

  • 投資者網路
    • 對智慧藥丸技術的聯邦政府補助金
    • 公共資金供給團體
    • 機構投資者、個人投資家
  • 技術培育
    • 政府/聯邦技術培育
    • 企業技術培育
  • 資金供給模式、投資者的趨勢
  • 現在及未來的技術投資機會相關考察
    • 授權、收購可利用的技術的評估
    • 技術投資的潛在的引進領域分析
  • AHP為基礎的智慧藥丸技術的組合分析

第7章 智慧藥丸市場地區分析

  • 南北美洲
    • 北美
    • 南美
  • 歐洲
  • 中東、非洲
  • 亞太地區

第8章 競爭環境

  • M&A
  • 聯盟、合作
  • 技術為基礎的倡議(計劃)

第9章 分析師的考察、建議

  • 開發者的智能偵察及資金籌措的策略性建議
  • 市場機會打開

第10章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3264

The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases.

The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014. On the basis of regions, North America is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the favorable reimbursement scenario, FDA approvals for smart pills, and investment by government and other agencies.

The smart pills market has few players as two major segments of the market are under R&D phase. The companies in this market focus on growth strategies such as new product launches; agreements, partnerships, collaborations, and others (approvals and expansion) to increase their customer base.

The major players in the global smart pills market include CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the 10 major players in the smart pills market. The report analyzes the smart pills technology across geographies
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the smart pills market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the smart pills market across geographies
  • Market Diversification: Extensive information about new products and services, untapped geographies, recent developments, and investments in the smart pills market
  • Competitive Assessment: In-depth assessment of strategies, products, and services of the leading players in the smart pills market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY & PRICING
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.1.1. SECONDARY RESEARCH
    • 2.1.2. KEY DATA FROM SECONDARY SOURCES
    • 2.1.3. PRIMARY RESEARCH
      • 2.1.3.1. Key data from primary sources
      • 2.1.3.2. Key insights from primary sources
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. MARKET FORECAST METHODOLOGY
    • 2.2.2. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE MARKET OPPORTUNITIES IN THE SMART PILLS MARKET
  • 4.2. GLOBAL SMART PILLS MARKET, BY APPLICATION
  • 4.3. GROWTH RATE ACROSS GEOGRAPHIES
  • 4.4. SMART PILLS MARKET: LIFE CYCLE ANALYSIS, BY GEOGRAPHY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. SMART PILLS MARKET, BY APPLICATION
    • 5.2.2. SMART PILLS MARKET, BY GEOGRAPHY
  • 5.3. MARKET DYNAMICS
  • 5.4. DRIVERS
    • 5.4.1. FAVORABLE REIMBURSEMENT SCENARIO
    • 5.4.2. PATIENT PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
    • 5.4.3. TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES
    • 5.4.4. INCREASE IN INCIDENCE OF COLON CANCER
    • 5.4.5. BOWEL SCOPE SCREENING IS EXPECTED TO HAVE A POSITIVE IMPACT ON THE ENDOSCOPY MARKET IN THE U.K.
    • 5.4.6. GROWTH IN AGING POPULATION
  • 5.5. RESTRAINTS
    • 5.5.1. TECHNOLOGICAL LIMITATIONS IN TERMS OF TAKING IMAGES OF A PARTICULAR SITE AND RETENTION OF CAPSULE
    • 5.5.2. INCREASING TECHNOLOGICAL SOPHISTICATION IN SMART PILLS TO INCREASE THEIR COST
  • 5.6. OPPORTUNITIES
    • 5.6.1. NEED FOR A RAPID DRUG DEVELOPMENT PROCESS
  • 5.7. PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1. THREAT OF NEW ENTRANTS
    • 5.7.2. THREAT OF SUBSTITUTES
    • 5.7.3. BARGAINING POWER OF BUYERS
    • 5.7.4. BARGAINING POWER OF SUPPLIERS
    • 5.7.5. INTENSITY OF COMPETITIVE RIVALRY

6. SMART PILLS TECHNOLOGY MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. CAPSULE ENDOSCOPES
    • 6.2.1. OVERVIEW
    • 6.2.2. CAPSULE ENDOSCOPES: COMPONENTS
      • 6.2.2.1. Components
    • 6.2.3. PILLCAM COLON BY GIVEN IMAGING
      • 6.2.3.1. Interactive colon exam comparison tool
    • 6.2.4. CURRENTLY MARKETED PRODUCTS WITH SPECIFICATIONS
    • 6.2.5. CAPSULE ENDOSCOPES MARKET SIZE
  • 6.3. SMART PILLS FOR PATIENT MONITORING
    • 6.3.1. SMART PILLS FOR PATIENT MONITORING: OVERVIEW
    • 6.3.2. PROTEUS DIGITAL HEALTH
    • 6.3.3. SMART PILLS FOR PATIENT MONITORING: MARKET SIZE
    • 6.3.4. SMART PILLS FOR PATIENT MONITORING: FUTURE POTENTIAL
  • 6.4. SMART PILLS FOR DRUG DELIVERY
    • 6.4.1. SMART PILLS FOR DRUG DELIVERY: OVERVIEW
    • 6.4.2. INTELLICAP SYSTEM BY MEDIMETRICS
    • 6.4.3. SMART PILLS FOR DRUG DELIVERY: MARKET SIZE
    • 6.4.4. SMART PILLS FOR DRUG DELIVERY: FUTURE POTENTIAL

7. RESEARCH LANDSCAPE

  • 7.1. THE MELODY PROJECT
  • 7.2. EDIBLE BATTERY TO TARGET HEALTH SENSORS AND DRUG DELIVERY
  • 7.3. LASER PILL FOR ESOPHAGUS IMAGING
  • 7.4. MAARS REMOTE-CONTROLLED MAGNETIC CAPSULE
  • 7.5. DESIGN AND IMPLEMENTATION OF MINIATURIZED CAPSULES FOR AUTO-FLUORESCENCE DETECTION WITH POSSIBLE APPLICATIONS IN BOWEL DISEASE
  • 7.6. DETECTING A SECRETED GASTRIC CANCER BIOMARKER MOLECULE BY TARGETED NANOPARTICLES FOR REAL-TIME DIAGNOSTICS
  • 7.7. MAGNETICALLY ACTUATED SOFT CAPSULE ENDOSCOPE (MASCE)
  • 7.8. POWER GENERATION TECHNOLOGY USING BENDABLE THIN FILM NANO-MATERIALS
  • 7.9. WIRELESSLY COMMUNICATING CAPSULE PROTOTYPE
  • 7.10. DEVELOPMENT OF CMOS SENSORS FOR INCORPORATION IN ENDOSCOPIC CAPSULES FOR CANCER CELLS
  • 7.11. VERSATILE ENDOSCOPIC CAPSULE FOR GASTROINTESTINAL TUMOR RECOGNITION AND THERAPY: VECTOR
  • 7.12. NOVEL, INNOVATIVE, REMOTE-CONTROLLED DRUG DELIVERY CAPSULE
  • 7.13. DRUG DELIVERY WITH MUSCLE

8. SMART PILLS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
    • 8.2.2. CANADA
  • 8.3. EUROPE
    • 8.3.1. U.K.
    • 8.3.2. SPAIN
    • 8.3.3. GERMANY
    • 8.3.4. FRANCE
    • 8.3.5. ITALY
    • 8.3.6. REST OF EUROPE
  • 8.4. ASIA
    • 8.4.1. JAPAN
    • 8.4.2. CHINA
    • 8.4.3. INDIA
    • 8.4.4. REST OF ASIA (ROA)
  • 8.5. REST OF THE WORLD (ROW)
  • 8.6. PEST ANALYSIS
    • 8.6.1. POLITICAL FACTORS
    • 8.6.2. ECONOMIC FACTORS
    • 8.6.3. SOCIAL FACTORS
    • 8.6.4. TECHNOLOGICAL FACTORS

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. R&D INVESTMENT ANALYSIS, SMART PILLS MARKET
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 9.3.2. NEW PRODUCT LAUNCHES
  • 9.4. EXPANSIONS
  • 9.5. OTHER DEVELOPMENTS
  • 9.6. MERGERS AND ACQUISITIONS

10. COMPANY PROFILES

  • 10.1. ACAMP
    • 10.1.1. BUSINESS OVERVIEW
    • 10.1.2. ACAMP: COMPANY SNAPSHOT
    • 10.1.3. PRODUCT PORTFOLIO
  • 10.2. BIO-IMAGES RESEARCH LTD.
    • 10.2.1. BUSINESS OVERVIEW
    • 10.2.2. SERVICE OFFERINGS
    • 10.2.3. RECENT DEVELOPMENTS
  • 10.3. BOSTON SCIENTIFIC CORPORATION
    • 10.3.1. BUSINESS OVERVIEW
    • 10.3.2. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • 10.3.3. KEY STRATEGY
      • 10.3.3.1. Focus on research and development:
  • 10.4. CAPSOVISION, INC.
    • 10.4.1. BUSINESS OVERVIEW
    • 10.4.2. PRODUCT PORTFOLIO
    • 10.4.3. KEY STRATEGY
      • 10.4.3.1. Market development:
    • 10.4.4. RECENT DEVELOPMENTS
  • 10.5. GIVEN IMAGING, INC.
    • 10.5.1. BUSINESS OVERVIEW
    • 10.5.2. MEDTRONIC, INC.: COMPANY SNAPSHOT
    • 10.5.3. PRODUCT PORTFOLIO:
    • 10.5.4. KEY STRATEGY
      • 10.5.4.1. FDA Approvals:
    • 10.5.5. RECENT DEVELOPMENTS
  • 10.6. MEDIMETRICS S.A. DE C.V.
    • 10.6.1. BUSINESS OVERVIEW
    • 10.6.2. PRODUCTS AND SERVICES
    • 10.6.3. KEY STRATEGY
      • 10.6.3.1. Partnerships and collaborations:
    • 10.6.4. RECENT DEVELOPMENTS
  • 10.7. OLYMPUS CORPORATION
    • 10.7.1. BUSINESS OVERVIEW
    • 10.7.2. OLYMPUS CORPORATION: COMPANY SNAPSHOT
    • 10.7.3. PRODUCT PORTFOLIO
    • 10.7.4. KEY STRATEGY
      • 10.7.4.1. New Product Launches
    • 10.7.5. RECENT DEVELOPMENTS
  • 10.8. PROTEUS DIGITAL HEALTH, INC.
    • 10.8.1. BUSINESS OVERVIEW
    • 10.8.2. PRODUCT PORTFOLIO
    • 10.8.3. KEY STRATEGY
      • 10.8.3.1. Partnerships and Collaborations
    • 10.8.4. RECENT DEVELOPMENTS

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING INCIDENCE OF THE CANCERS IN MEN GLOBALLY DRIVES THE SMART PILL MARKET
  • TABLE 2: INCREASING INCIDENCE OF THE CANCERS IN WOMEN GLOBALLY DRIVES THE SMART PILL MARKET
  • TABLE 3: COLORECTAL CANCER: ESTIMATED INCIDENCE, MORTALITY AND PREVALENCE WORLDWIDE IN 2012
  • TABLE 4: COUNTRIES WITH HIGHEST INCIDENCE OF COLORECTAL CANCER IN 2012 (BOTH SEXES)
  • TABLE 5: SMART PILLS MARKET SIZE, BY APPLICATION, 2014-2024 ($MILLION)
  • TABLE 6: SMART PILLS MARKET SIZE FOR CAPSULE ENDOSCOPES, BY REGION, 2014-2024 ($MILLION)
  • TABLE 7: CAPSULE ENDOSCOPES MARKET SIZE FOR SMALL INTESTINE, BY REGION, 2014-2024 ($MILLION)
  • TABLE 8: CAPSULE ENDOSCOPES MARKET SIZE FOR COLON, BY REGION, 2014-2024 ($ MILLION)
  • TABLE 9: CAPSULE ENDOSCOPES MARKET SIZE FOR OTHER CAPSULE ENDOSCOPY, BY REGION, 2014-2024 ($ MILLION)
  • TABLE 10: SMART PILLS MARKET SIZE FOR PATIENT MONITORING, BY REGION, 2014-2024 ($MILLION)
  • TABLE 11: SMART PILLS MARKET SIZE FOR DRUG DELIVERY, BY REGION, 2014-2024 ($MILLION)
  • TABLE 12: SMART PILLS MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 13: NORTH AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 14: NORTH AMERICA: SMART PILLS MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 15: NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 16: NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 17: NORTH AMERICA: DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 18: NORTH AMERICA: PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2012-2024 ($MILLION)
  • TABLE 19: US: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 20: US: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 21: CANADA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 22: CANADA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 23: EUROPE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 24: EUROPE: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 25: EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 26: EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION, 2014-2024 ($MILLION)
  • TABLE 27: EUROPE: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 28: EUROPE: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 29: UK: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 30: UK: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 31: SPAIN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 32: SPAIN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 33: GERMANY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 34: GERMANY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 35: FRANCE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 36: FRANCE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 37: ITALY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 38: ITALY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 39: ROE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 40: ROE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 41: ASIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 42: ASIA: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 43: ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 44: ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 45: ASIA: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 46: ASIA: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION, 2012-2024 ($MILLION)
  • TABLE 47: JAPAN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 48: JAPAN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 49: CHINA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 50: CHINA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 51: INDIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 52: INDIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 53: ROA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 54: ROA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 55: ROW: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 56: ROW: SMART PILLS MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 57: ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 58: ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 59: ROW: DRUG DELIVERY MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 60: ROW: PATIENT MONITORING MARKET SIZE, BY REGION, 2012-2024 ($MILLION)
  • TABLE 61: LATIN AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 62: LATIN AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 63: PACIFIC COUNTRIES: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 64: PACIFIC COUNTRIES: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 65: MIDDLE EAST & AFRICA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012-2024 ($MILLION)
  • TABLE 66: MIDDLE EAST & AFRICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012-2024 ($MILLION)
  • TABLE 67: AGREEMENTS AND COLLABORATIONS, 2012-2014
  • TABLE 68: NEW PRODUCT LAUNCHES, 2012-2014
  • TABLE 69: EXPANSIONS, 2012-2014
  • TABLE 70: OTHER DEVELOPMENTS, 2012-2014
  • TABLE 71: MERGERS AND ACQUISITIONS, 2012-2014
  • TABLE 72: EXCHANGE RATES (USED FOR CONVERSION OF YEN TO USD)

LIST OF FIGURES

  • FIGURE 1: SMART PILLS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH METHODOLOGY DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: MARKET FORECAST METHODOLOGY
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: ROW TO WITNESS THE HIGHEST GROWTH RATE IN THE CAPSULE ENDOSCOPY MARKET FROM 2014 TO 2024
  • FIGURE 9: SMART PILLS MARKET SIZE, BY REGION(2014)
  • FIGURE 10: SMART PILLS MARKET SIZE, BY APPLICATION (2014 VS. 2024)
  • FIGURE 11: SMART PILLS MARKET TO GROW AT A CAGR OF 16% FROM 2014 TO 2020, CAGR OF 23% FROM 2020 TO 2024
  • FIGURE 12: CAPSULE ENDOSCOPY SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL SMART PILLS MARKET, 2014
  • FIGURE 13: ROW TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2020-2024)
  • FIGURE 14: ROW MARKET TO WITNESS HIGHEST GROWTH IN THE NEAR FUTURE(2020-2024)
  • FIGURE 15: SMART PILLS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 16: SMART PILLS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 17: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18: CAPSULE ENDOSCOPES DOMINATION IN THE SMART PILLS MARKET IN 2014 VS 2020
  • FIGURE 19: ROW HAS HIGHEST GROWTH IN THE FORECASTED PERIOD 2014-2020 ($MILLION)
  • FIGURE 20: NORTH AMERICAN MARKET TO WITNESS THE HIGHEST CAGR
  • FIGURE 21: CAPSULE ENDOSCOPY SEGMENT TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 22: COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
  • FIGURE 23: SMART PILLS MARKET: R&D EXPENDITURE SHARE, BY KEY PLAYER, 2014
  • FIGURE 24: BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS WAS THE KEY GROWTH STRATEGY
  • FIGURE 25: GEOGRAPHICAL PRESENCE OF THE TOP PLAYERS OF THE SMART PILLS MARKET
Back to Top